News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ADPT market cap is 1.11B. The company's latest EPS is USD -1.0734 and P/E is -7.35.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 45.78M | 41.87M | 43.19M | 46.44M | 47.46M |
| Operating Income | -45.64M | -48.76M | -40.11M | -39.84M | -33.84M |
| Net Income | -69.44M | -47.51M | -46.22M | -32.15M | -33.61M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 98.38M | 154.34M | 185.31M | 170.28M | 178.96M |
| Operating Income | -152.82M | -208.97M | -200.19M | -201.61M | -162.55M |
| Net Income | -146.23M | -207.28M | -200.19M | -225.25M | -159.49M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 661.13M | 620.32M | 584.87M | 558.51M | 539.38M |
| Total Liabilities | 352.86M | 345.56M | 343.44M | 334.93M | 336.89M |
| Total Equity | 308.28M | 274.77M | 241.43M | 223.57M | 202.49M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.12B | 923.34M | 856.62M | 661.13M | 539.38M |
| Total Liabilities | 373.15M | 319.24M | 392.52M | 352.86M | 336.89M |
| Total Equity | 743.27M | 604.1M | 464.1M | 308.28M | 202.49M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -156.32M | -38.35M | -55.66M | -82.72M | -95.21M |
| Investing | 129.65M | 44.51M | 50.39M | 55.67M | 77.79M |
| Financing | 2.25M | 44k | 74k | 114k | 241k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -149.68M | -192.73M | -183.95M | -156.32M | -95.21M |
| Investing | -117.04M | 181.21M | 2.91M | 129.65M | 77.79M |
| Financing | 293.59M | 27.15M | 132.27M | 2.25M | 241k |
| Market Cap | 1.11B |
| Price to Earnings Ratio | -7.35 |
| Price to Sales Ratio | 6.55 |
| Price to Cash Ratio | 24.47 |
| Price to Book Ratio | 5.79 |
| Dividend Yield | - |
| Shares Outstanding | 148.58M |
| Average Volume (1 week) | 2.02M |
| Average Volume (1 Month) | 2.39M |
| 52 Week Change | 195.28% |
| 52 Week High | 9.01 |
| 52 Week Low | 2.48 |
| Spread (Intraday) | 3.75 (42.86%) |
| Company Name | Adaptive Biotechnologies Corporation |
| Address |
711 capitol way s ste 204 olympia, washington 98501 1267 |
| Website | https://www.adaptivebiotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
